| Literature DB >> 24938388 |
Jonathan Richard Ellenbogen1, Mueez Waqar2, David W Denning3, Richard P D Cooke4, Derek W Skinner5, Tristram Lesser6, Mohsen Javadpour7.
Abstract
Cerebral aspergillosis is a rare manifestation of invasive aspergillosis that usually affects immunocompromised patients. There are few treatment options for recurrent disease and experiences with immunocompetent patients are lacking. We report the clinical course of an immunocompetent patient with recurrent cerebral aspergillosis, following initial treatment with burr hole aspiration and voriconazole, who showed remarkable response to posaconazole. The patient remains clinically well with no evidence of recurrence on MRI 7 years following diagnosis. To our knowledge this is the first reported experience with posaconazole in an immunocompetent patient with cerebral aspergillosis.Entities:
Keywords: Aspergillosis; Central nervous system; Immunocompetent; Posaconazole; Voriconazole
Mesh:
Substances:
Year: 2014 PMID: 24938388 DOI: 10.1016/j.jocn.2014.05.004
Source DB: PubMed Journal: J Clin Neurosci ISSN: 0967-5868 Impact factor: 1.961